Outset Medical presentation, links

 Outset Medical

Investor Presentation

January 2025

Catalyzing profound and permanent change in where, when and how dialysis is delivered.

Outset Medical, Inc. - Confidential & Proprietary - Do Not Distribute

Investment Highlights

Large markets served by a technology with deep and durable competitive advantage

Growing footprint and scale with hundreds of customers and >1,000,000 treatments performed per year

Recurring revenue model powered by predictable utilization

Commercial transformation focused on reigniting growth

Capitalized through breakeven and well-positioned to prosecute our mission

CURRENT STATE

Dialysis is one of the largest, most expensive, least-changed sectors of healthcare

2022

2030

$73B1	$41B1	7%2	for 1%2	30%3
Annual spending on	Paid by Medicare
U.S. ESRD patients

600,0003

Dialysis patients

90M3

Annual dialysis treatments

1. Company estimates based on data contained in USRDS 2021 Annual Data Report
2. Percentage of entire Medicare budget spent on dialysis for ESRD patients, who comprise 1% of the Medicare population (2019)
3. Company estimates based on data contained in USRDS 2022 Annual Data Report

Patient Journey Spans Hospital to Home

CKD/ESRD PATIENTS

POST ACUTE

ACUTEFACILITIES

60%

CRASH INTO

DIALYSIS

600,000 Total U.S. dialysis patients

40%

MANAGED INTO

DIALYSIS

MID-SIZED DIALYSIS

OPERATORS

HOME

Note: "CKD" represents Chronic Kidney Disease; "ESRD" represents End Stage Renal Disease Company estimates based on data contained in U.S. Renal Data System's 2021 Annual Data Report

1 Represents total short- and long-term nursing home care as reported in Chen S et al., Nursing Home Status Adjustment for Standardized Mortality and Hospitalization in Dialysis Facility Reports. Kidney Med.

2 Company estimates based on data contained in USRDS 2022 Annual Data Report; 600,000 ESRD patients, 70% under care by the LDOs and 30% (180,000 patients) under care of non-LDOs

6

Outset Medical, Inc. - Confidential & Proprietary - Do Not Distribute

CURRENT STATE

Dialysis needs new solutions

Costly

Complicated

Antiquated

Outset Medical, Inc. - Confidential & Proprietary - Do Not Distribute

We see

1. technology-drivenway forward

Tablo® is a first-of-its- kind technology designed to reduce the cost and complexity of dialysis

Single device from ICU to home

Connected and intelligent

Small and mobile

One device, multiple markets

$11.4B

U.S. TAM

Company estimates based on data contained in USRDS 2021 Annual Data Report

$2.5B

Acute and Post-Acute Market

$8.9B

Home market

One device, multiple markets

$11.4B

U.S. TAM

Company estimates based on data contained in USRDS 2021 Annual Data Report

$2.5B

Acute and Post-Acute Market

$8.9B

Home market

Attachments

• Original document
• Permalink

https://www.marketscreener.com/quote/stock/OUTSET-MEDICAL-INC-112388686/news/Outset-Medical-Investor-Presentation-January-2025-48790081/